 LAS VEGAS, Jan. 29, 2021 PRNewswire -- JanOne Inc. NASDAQ: JAN, a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced it has entered into a securities purchase agreement with... 